Lisa Götz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lisa Götz has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Alireza Paikari
Theodor-Boveri-Institute/Biocenter, Developmental Biochemistry, Julius-Maximilians-University Würzburg, Würzburg, Germany
1 shared publication Christian Vokuhl
Section of Pediatric Pathology, Department of Pathology, University Hospital Bonn, Bonn, Germany
1 shared publicationChristin Linderkamp
Department of Pediatric Hematology and Oncology, Hannover Medical School (MHH), Hannover, Germany
1 shared publication- Dominik T. Schneider
Clinic of Pediatrics Klinikum Dortmund University Witten/Herdecke Dortmund Germany
1 shared publication - Florian Kleefeldt
Institute of Anatomy and Cell Biology, University of Würzburg, 97070 Würzburg, Germany
1 shared publication Jarno Drost
Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
1 shared publication
Latest Publications
- Open Access
- 24 August 2026
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 17 (9) , 425
Hydrogel-Dependent Angiogenic Sprouting in the Ex Vivo Aortic Ring Assay: A Comparative Functional Approach for Biomaterial Evaluation
Insufficient vascularization remains a major limitation in tissue engineering, restricting the survival and maturation of larger bioengineered constructs. While candidate hydrogels are commonly characterized with regard to physicochemical properties, gelation behavior, mechanical performance, and cytocompatibility, simple functional assays that assess their capacity to support vascular sprouting are less frequently integrated into early-stage biomaterial evaluation. Here, we investigated the established ex vivo aortic ring assay (ARA) as an exploratory functional approach for the initial comparison of selected hydrogel formulations. Murine aortic rings were embedded in collagen I (Col I), alginate (Alg), or gelatin methacryloyl (GelMA) and cultured under control conditions or with vascular endothelial growth factor A (VEGF-A) stimulation. These hydrogels were intentionally selected as a proof-of-concept panel of representative, non-equivalent material classes with distinct expected cell-interactive properties. After five days, Col I supported robust capillary-like outgrowth that was further enhanced by VEGF-A, whereas the tested GelMA formulation supported only limited cellular migration and the tested unmodified Alg formulation showed no detectable sprouting under the conditions examined. Cluster of differentiation 31 (CD31) immunostaining supported the presence of an endothelial component within the Col I-supported sprouting structures. These findings demonstrate that the ARA can detect pronounced formulation-dependent differences among the specific hydrogels tested using straightforward morphological and immunostaining readouts. Within the scope of the formulations tested, these findings support the ARA as a complementary functional readout alongside conventional biomaterial characterization before more complex tissue engineering or biofabrication studies are performed.
- 24 August 2026
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 17 (9) , 425
Open AccessHydrogel-Dependent Angiogenic Sprouting in the Ex Vivo Aortic Ring Assay: A Comparative Functional Approach for Biomaterial Evaluation
Insufficient vascularization remains a major limitation in tissue engineering, restricting the survival and maturation of larger bioengineered constructs. While candidate hydrogels are commonly characterized with regard to physicochemical properties, gelation behavior, mechanical performance, and cytocompatibility, simple functional assays that assess their capacity to support vascular sprouting are less frequently integrated into early-stage biomaterial evaluation. Here, we investigated the established ex vivo aortic ring assay (ARA) as an exploratory functional approach for the initial comparison of selected hydrogel formulations. Murine aortic rings were embedded in collagen I (Col I), alginate (Alg), or gelatin methacryloyl (GelMA) and cultured under control conditions or with vascular endothelial growth factor A (VEGF-A) stimulation. These hydrogels were intentionally selected as a proof-of-concept panel of representative, non-equivalent material classes with distinct expected cell-interactive properties. After five days, Col I supported robust capillary-like outgrowth that was further enhanced by VEGF-A, whereas the tested GelMA formulation supported only limited cellular migration and the tested unmodified Alg formulation showed no detectable sprouting under the conditions examined. Cluster of differentiation 31 (CD31) immunostaining supported the presence of an endothelial component within the Col I-supported sprouting structures. These findings demonstrate that the ARA can detect pronounced formulation-dependent differences among the specific hydrogels tested using straightforward morphological and immunostaining readouts. Within the scope of the formulations tested, these findings support the ARA as a complementary functional readout alongside conventional biomaterial characterization before more complex tissue engineering or biofabrication studies are performed.
- Open Access
- 30 December 2024
- Published by Elsevier in Translational Oncology
- Vol. 52, 102263
Wilms tumor primary cultures capture phenotypic heterogeneity and facilitate preclinical screening
- 30 December 2024
- Published by Elsevier in Translational Oncology
- Vol. 52, 102263
Open AccessWilms tumor primary cultures capture phenotypic heterogeneity and facilitate preclinical screening